Concepedia

Frédéric Doublet

FD

4

Publications

183

Citations

4

H-Index

2007

Active since

Affiliations

KU Leuven(Current)

Janssen (France)

Rega Institute for Medical Research

Global Virus Network

Janssen (Belgium)

Frédéric Doublet is an author at KU Leuven specializing in medicinal chemistry, medicine, and drug discovery.

Top concepts

Publications per year

2007–2024

4

Publications

4

Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate. 2. Discovery of a Morpholinopropylaminobenzimidazole Derivative (TMC353121)

Jean‐François Bonfanti, Christophe Meyer, Frédéric Doublet et al. · Journal of Medicinal Chemistry · 2008 · 97 citations

Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate, Part 1:  Improving the Pharmacokinetic Profile Using the Structure−Property Relationship

Jean‐François Bonfanti, Frédéric Doublet, Jérôme Fortin et al. · Journal of Medicinal Chemistry · 2007 · 50 citations

, , +19

Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B Inhibitor

Bart Kesteleyn, Jean‐François Bonfanti, Dorothée Bardiot et al. · Journal of Medicinal Chemistry · 2024 · 25 citations

Discovery of Acyl-Indole Derivatives as Pan-Serotype Dengue Virus NS4B Inhibitors

Bart Kesteleyn, Dorothée Bardiot, Jean‐François Bonfanti et al. · Journal of Medicinal Chemistry · 2023 · 11 citations · Full text

Rows per page

1–4 of 4